Epidemiology of Chronic Hepatitis B in Turkey
| dc.contributor.author | Özkan, Hasan | |
| dc.contributor.department | Tıp Fakültesi | tr_TR |
| dc.date.accessioned | 2021-01-05T07:36:17Z | |
| dc.date.available | 2021-01-05T07:36:17Z | |
| dc.date.issued | 2018 | |
| dc.description.abstract | Hepatitis B virus (HBV) infection is a global public health problem and it is also a major health concern of Turkey. The estimated number of HBV carriers in Turkey is about 3.3 million, with an overall HBV prevalence of 4.57%. Thus, both prevention and therapy of HBV-infected patients are urgent medical need of Turkey. A total of 1,533 among 37,637 patients who were examined at the Department of Gastroenterology, Ankara University School of Medicine were found to be hepatitis B surface antigen (HBsAg) positive (4%). Viral hepatitis treatment is fully reimbursed in Turkey through the national insurance system, which covers all residents across Turkey. How to cite this article: Özkan H. Epidemiology of Chronic Hepatitis B in Turkey. Euroasian J Hepato-Gastroenterol 2018;8(1):73-74. | tr_TR |
| dc.description.index | Pubmed | |
| dc.identifier.endpage | 74 | tr_TR |
| dc.identifier.issue | 1 | tr_TR |
| dc.identifier.startpage | 73 | tr_TR |
| dc.identifier.uri | https://doi.org/10.5005/jp-journals-10018-1264 | tr_TR |
| dc.identifier.uri | http://hdl.handle.net/20.500.12575/72620 | |
| dc.identifier.volume | 8 | tr_TR |
| dc.language.iso | en | tr_TR |
| dc.relation.isversionof | 10.5005/jp-journals-10018-1264 | tr_TR |
| dc.relation.journal | Euroasian J Hepatogastroenterol . | tr_TR |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | tr_TR |
| dc.subject | Hepatitis B virus | tr_TR |
| dc.subject | Management | tr_TR |
| dc.subject | National support | tr_TR |
| dc.title | Epidemiology of Chronic Hepatitis B in Turkey | tr_TR |
| dc.type | Article | tr_TR |